Insider · CIK 0001224962
Perceptive Advisors LLC
Files at ALDX (Aldeyra Therapeutics, Inc.), SLDB (Solid Biosciences Inc.), MGTX (MeiraGTx Holdings plc), ACRV (Acrivon Therapeutics, Inc.), ADGM (Adagio Medical Holdings, Inc.). First filing Feb 21, 2025, latest May 1, 2025.
Where the trades landed
Last year at the 3 companies this insider has traded most, with each buy and sell on the bar it happened.
ACRV: Acrivon Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
ALDX: Aldeyra Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
SLDB: Solid Biosciences Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | ACRVsell Acrivon Therapeutics, Inc. | $1.0M 736,767 shares | -19% | - | |
| 47Moderate | ACRVsell Acrivon Therapeutics, Inc. | $2.7M 1,519,952 shares | -28% | - | |
| 47Moderate | ALDXsell Aldeyra Therapeutics, Inc. | $4.8M 3,400,000 shares | -37% | 0% from low-80% from high | |
| 65Notable | Solid Biosciences Inc. | $20M 5,000,000 shares | +73% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | MGTX MeiraGTx Holdings plc | AGrant or award Restricted Share Unitsderivativeindirect: See Footnote | +45,000 | $0.00 | $0 | 45,000 | Jun 16, 2025 |
| Jun 12, 2025 | SLDB Solid Biosciences Inc. | AGrant or award Director Stock Option (Right to Buy)derivativeindirect: See Footnotes | +77,500 | $0.00 | $0 | 77,500 | Jun 13, 2025 |
| Apr 30, 2025 | ACRV Acrivon Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -437,881 | $1.41 | $617k | 3,403,025 | May 1, 2025 |
| May 1, 2025 | ACRV Acrivon Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -298,886 | $1.34 | $401k | 3,104,139 | May 1, 2025 |
| Apr 25, 2025 | ACRV Acrivon Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -1,054,669 | $1.95 | $2.1M | 4,306,189 | Apr 29, 2025 |
| Apr 28, 2025 | ACRV Acrivon Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -215,283 | $1.56 | $336k | 4,090,906 | Apr 29, 2025 |
| Apr 29, 2025 | ACRV Acrivon Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -250,000 | $1.41 | $353k | 3,840,906 | Apr 29, 2025 |
| Apr 3, 2025 | ALDX Aldeyra Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -3,400,000 | $1.42 | $4.8M | 5,875,851 | Apr 7, 2025 |
| Feb 19, 2025 | SLDB Solid Biosciences Inc. | POpen-market purchase Common Stockindirect: See footnote | +5,000,000 | $4.03 | $20M | 11,833,539 | Feb 21, 2025 |
| Jan 22, 2025 | ADGM Adagio Medical Holdings, Inc. | AGrant or award Common Stock | +64,167 | - | - | 9,675,684 | Feb 14, 2025 |
| Jun 11, 2024 | SLDB Solid Biosciences Inc. | AGrant or award Director Stock Option (Right to Buy)derivativeindirect: See Footnotes | +34,400 | $0.00 | $0 | 34,400 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.